Over the past three decades, apoptosis and other modes of regulated cell death, together with the transcription regulators p53 and p21WAF1 (p21), have been among the most extensively studied and highly reviewed fields in the context of cancer progression and therapy. The gene discussed is TP53; the disease is cancer.